-
公开(公告)号:US20080038265A1
公开(公告)日:2008-02-14
申请号:US11614772
申请日:2006-12-21
申请人: Edward Reilly , Susan Lacy , Emma Fung , Jonathan Belk , Michael Roguska , Vincent Stoll , Clarissa Jakob
发明人: Edward Reilly , Susan Lacy , Emma Fung , Jonathan Belk , Michael Roguska , Vincent Stoll , Clarissa Jakob
IPC分类号: A61K39/395 , A61P43/00 , C07K16/24 , C07K7/06 , G06G7/60
CPC分类号: C07K16/2863 , C07K2317/21 , C07K2317/34 , C07K2317/565 , C07K2317/622 , C07K2317/74 , C07K2317/92
摘要: The present invention relates to antibodies and antigen-binding portions thereof that bind to and activate an erythropoietin receptor. The invention also relates to nucleic acid sequences encoding such antibodies and antigen-binding portions. The present invention further relates to methods of activating the endogenous activity of an erythropoietin receptor in a mammal using said antibodies and antigen-binding portions, methods of treatment, as well as pharmaceutical compositions comprising said antibodies and antigen-binding portions. The invention further provides compositions and crystals of an erythropoietin receptor in complex with an anti-erythropoietin receptor antibody. Specifically, the high-resolution structure provides binding sites defined by the structure coordinated determined herein.
摘要翻译: 本发明涉及结合并激活促红细胞生成素受体的抗体及其抗原结合部分。 本发明还涉及编码这种抗体和抗原结合部分的核酸序列。 本发明还涉及使用所述抗体和抗原结合部分,治疗方法以及包含所述抗体和抗原结合部分的药物组合物来激活哺乳动物中促红细胞生成素受体的内源性活性的方法。 本发明还提供与抗促红细胞生成素受体抗体复合的促红细胞生成素受体的组合物和晶体。 具体地,高分辨率结构提供由本文确定的结构所定义的结合位点。
-
公开(公告)号:US20130005705A1
公开(公告)日:2013-01-03
申请号:US13534127
申请日:2012-06-27
申请人: Hervé Geneste , Michael Ochse , Karla Drescher , Berthold Behl , Loic Laplanche , Jürgen Dinges , Clarissa Jakob
发明人: Hervé Geneste , Michael Ochse , Karla Drescher , Berthold Behl , Loic Laplanche , Jürgen Dinges , Clarissa Jakob
IPC分类号: A61K31/4709 , C07D401/14 , A61K31/517 , C07D413/14 , C07D495/04 , A61K31/444 , C07D405/14 , A61K31/506 , A61K31/5377 , A61K31/496 , C07D417/14 , A61K31/541 , C07D491/107 , A61K31/501 , A61P25/28 , A61P3/04 , A61P25/16 , A61P25/22 , A61P25/00 , A61P25/18 , C07D471/04
CPC分类号: C07D471/04 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14
摘要: The present invention relates to novel carboxamide compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating or controlling medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.
摘要翻译: 本发明涉及新的羧酰胺化合物,含有它们的药物组合物及其在治疗中的用途。 所述化合物具有有价值的治疗性质,并且特别适用于治疗或控制选自神经障碍和精神障碍的医学病症,用于改善与此类疾病相关的症状并降低此类疾病的风险。
-
公开(公告)号:US09938269B2
公开(公告)日:2018-04-10
申请号:US13534127
申请日:2012-06-27
申请人: Hervé Geneste , Michael Ochse , Karla Drescher , Berthold Behl , Loic Laplanche , Jürgen Dinges , Clarissa Jakob , Katja Jantos
发明人: Hervé Geneste , Michael Ochse , Karla Drescher , Berthold Behl , Loic Laplanche , Jürgen Dinges , Clarissa Jakob , Katja Jantos
IPC分类号: C07D471/04 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14
CPC分类号: C07D471/04 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14
摘要: The present invention relates to novel carboxamide compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating or controlling medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.
-
-